The Vienna Prograf and Endothelial Progenitor Cell Study
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2014
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Biomarker; Pharmacodynamics
- Acronyms Vienna-PEP-Study
- 07 Jun 2017 Biomarkers information updated
- 04 May 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2004-004209-98).
- 18 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.